Neurology Neuroimmunology & Neuroinflammation vol. 8 n. 1

Neurology Neuroimmunology & Neuroinflammation vol. 8 n. 1

Volumen:

Veure revista:

Neurology® Neuroimmunology & Neuroinflammation

Any publicació:

2021

En aquest número

Article
N2 year in review.
Autor/s:
Dalmau J, Dalakas MC, Kolson DL, Paul F, Zamvil SS.
Editor's Corner
Any publicació:
2021
Número de revista:
Neurology Neuroimmunology & Neuroinflammation vol. 8 n. 1
https://nn.neurology.org/content/8/1/e925
Editorial
Obesity's role in MS: An intervention target with possible interactions.
Autor/s:
Fitzgerald KC, Mowry EM.
Editorial
Any publicació:
2021
Número de revista:
Neurology Neuroimmunology & Neuroinflammation vol. 8 n. 1
https://nn.neurology.org/content/8/1/e932
Article
Chitinase 3-like 1 and neurofilament light chain in CSF and CNS atrophy in MS.
Autor/s:
Schneider R, Bellenberg B, Gisevius B, Hirschberg S, Sankowski R, Prinz M, Gold R, Lukas C, Haghikia A.
Any publicació:
2021
Número de revista:
Neurology Neuroimmunology & Neuroinflammation vol. 8 n. 1
https://nn.neurology.org/content/8/1/e906
Article
Mild progressive multifocal leukoencephalopathy after switching from natalizumab to ocrelizumab.
Autor/s:
Toorop AA, van Lierop ZYG, Strijbis EEM, Teunissen CE, Petzold A, Wattjes MP, Barkhof F, de Jong BA, van Kempen ZLE, Killestein J.
Any publicació:
2021
Número de revista:
Neurology Neuroimmunology & Neuroinflammation vol. 8 n. 1
https://nn.neurology.org/content/8/1/e904
Article
Clostridium bolteae is elevated in neuromyelitis optica spectrum disorder in India and shares sequence similarity with AQP4.
Autor/s:
Pandit L, Cox LM, Malli C, D'Cunha A, Rooney T, Lokhande H, Willocq V, Saxena S, Chitnis T...
Any publicació:
2021
Número de revista:
Neurology Neuroimmunology & Neuroinflammation vol. 8 n. 1
https://nn.neurology.org/content/8/1/e907
Article
Laquinimod dampens IL-1β signaling and Th17-polarizing capacity of monocytes in patients with MS.
Autor/s:
Engel S, Jolivel V, Kraus SH, Zayoud M, Rosenfeld K, Tumani H, Furlan R, Kurschus FC, Waisman A, Luessi F.
Any publicació:
2021
Número de revista:
Neurology Neuroimmunology & Neuroinflammation vol. 8 n. 1
https://nn.neurology.org/content/8/1/e908
Article
Anti-CD20 therapies and pregnancy in neuroimmunologic disorders: A cohort study from Germany.
Autor/s:
Kümpfel T, Thiel S, Meinl I, Ciplea AI, Bayas A, Hoffmann F, Hofstadt-van Oy U, Hoshi M, Kluge J, Ringelstein M, Aktas O, Stoppe M, Walter A, Weber MS, Ayzenberg I, Hellwig K.
Any publicació:
2021
Número de revista:
Neurology Neuroimmunology & Neuroinflammation vol. 8 n. 1
https://nn.neurology.org/content/8/1/e913
Article
Placental transfer of NMDAR antibodies causes reversible alterations in mice.
Autor/s:
García-Serra A, Radosevic M, Pupak A, Brito V, Ríos J, Aguilar E, Maudes E, Ariño H, Spatola M, Mannara F, Pedreño M, Joubert B, Ginés S, Planagumà J, Dalmau J.
Any publicació:
2021
Número de revista:
Neurology Neuroimmunology & Neuroinflammation vol. 8 n. 1
https://nn.neurology.org/content/8/1/e915
Article
Seizure-related 6 homolog like 2 autoimmunity: Neurologic syndrome and antibody effects.
Autor/s:
Landa J, Guasp M, Petit-Pedrol M, Martínez-Hernández E, Planagumà J, Saiz A, Ruiz-García R, García-Fernández L, Verschuuren J, Saunders-Pullman R, Ramirez-Gómez L, Geschwind MD, Dalmau J, Sabater L, Graus F.
Any publicació:
2021
Número de revista:
Neurology Neuroimmunology & Neuroinflammation vol. 8 n. 1
https://nn.neurology.org/content/8/1/e916
Article
Eastern equine encephalitis and use of IV immunoglobulin therapy and high-dose steroids.
Autor/s:
Wilcox DR, Collens SI, Solomon IH, Mateen FJ, Mukerji SS.
Any publicació:
2021
Número de revista:
Neurology Neuroimmunology & Neuroinflammation vol. 8 n. 1
https://nn.neurology.org/content/8/1/e917
Article
Time course of dementia following sepsis in German health claims data.
Autor/s:
Fritze T, Doblhammer G, Widmann CN, Heneka MT.
Any publicació:
2021
Número de revista:
Neurology Neuroimmunology & Neuroinflammation vol. 8 n. 1
https://nn.neurology.org/content/8/1/e911
Article
Mendelian randomization study shows no causal effects of serum urate levels on the risk of MS.
Autor/s:
Harroud A, Richards JB, Baranzini SE.
Any publicació:
2021
Número de revista:
Neurology Neuroimmunology & Neuroinflammation vol. 8 n. 1
https://nn.neurology.org/content/8/1/e920
Article
Overlapping central and peripheral nervous system syndromes in MOG antibody-associated disorders.
Autor/s:
Rinaldi S, Davies A, Fehmi J, Beadnall HN, Wang J, Hardy TA, Barnett MH, Broadley SA, Waters P, Reddel SW, Irani SR, Brilot F, Dale RC, Ramanathan S; Australian and New Zealand MOG Study Group.
Any publicació:
2021
Número de revista:
Neurology Neuroimmunology & Neuroinflammation vol. 8 n. 1
https://nn.neurology.org/content/8/1/e924
Article
High serum neurofilament associates with diffuse white matter damage in MS.
Autor/s:
Saraste M, Bezukladova S, Matilainen M, Tuisku J, Rissanen E, Sucksdorff M, Laaksonen S, Vuorimaa A, Kuhle J, Leppert D, Airas L.
Any publicació:
2021
Número de revista:
Neurology Neuroimmunology & Neuroinflammation vol. 8 n. 1
https://nn.neurology.org/content/8/1/e926
Article
Mesenchymal stem cell-derived neural progenitors in progressive MS: Two-year follow-up of a phase I study.
Autor/s:
Harris VK, Stark JW, Yang S, Zanker S, Tuddenham J, Sadiq SA.
Any publicació:
2021
Número de revista:
Neurology Neuroimmunology & Neuroinflammation vol. 8 n. 1
https://nn.neurology.org/content/8/1/e928
Article
Interleukin-15 enhances proinflammatory T-cell responses in patients with MS and EAE.
Autor/s:
Laurent C, Deblois G, Clénet ML, Carmena Moratalla A, Farzam-Kia N, Girard M, Duquette P, Prat A, Larochelle C, Arbour N.
Any publicació:
2021
Número de revista:
Neurology Neuroimmunology & Neuroinflammation vol. 8 n. 1
https://nn.neurology.org/content/8/1/e931
Article
Overweight/obesity in young adulthood interacts with aspects of EBV infection in MS etiology.
Autor/s:
Hedström AK, Brenner N, Butt J, Hillert J, Waterboer T, Olsson T, Alfredsson L.
Any publicació:
2021
Número de revista:
Neurology Neuroimmunology & Neuroinflammation vol. 8 n. 1
https://nn.neurology.org/content/8/1/e912
Article
LGI1 encephalitis with squamous lung-cell carcinoma: Resolution after tumor resection.
Autor/s:
Virupakshaiah A, Dalakas MC, Desai N, Mintzer S, Ratliff J.
Clinical/Scientific Notes
Any publicació:
2021
Número de revista:
Neurology Neuroimmunology & Neuroinflammation vol. 8 n. 1
https://nn.neurology.org/content/8/1/e905
Article
A case of neonatal onset multisystem inflammatory disease supporting a role of interleukin-1β in moyamoya syndrome.
Autor/s:
Wohlrab F, Bauknecht C, Meisel C, Dreier JP.
Clinical/Scientific Notes
Any publicació:
2021
Número de revista:
Neurology Neuroimmunology & Neuroinflammation vol. 8 n. 1
https://nn.neurology.org/content/8/1/e1
Article
Tumefactive inflammatory lesions in juvenile metachromatic leukodystrophy.
Autor/s:
Meier K, Gärtner J, Huppke P.
Clinical/Scientific Notes
Any publicació:
2021
Número de revista:
Neurology Neuroimmunology & Neuroinflammation vol. 8 n. 1
https://nn.neurology.org/content/8/1/e922
Article
Combination of teriflunomide and interferon as follow-up therapy after fingolimod-associated PML.
Autor/s:
Fischer-Barnicol B, Oechtering J, Kuhle J, Lorscheider J, Kappos L, Derfuss T.
Clinical/Scientific Notes
Any publicació:
2021
Número de revista:
Neurology Neuroimmunology & Neuroinflammation vol. 8 n. 1
https://nn.neurology.org/content/8/1/e927
Article de revisió
Intermediate uveitis associated with MS: Diagnosis, clinical features, pathogenic mechanisms, and recommendations for management.
Autor/s:
Abraham A, Nicholson L, Dick A, Rice C, Atan D.
Views and Reviews
Any publicació:
2021
Número de revista:
Neurology Neuroimmunology & Neuroinflammation vol. 8 n. 1
https://nn.neurology.org/content/8/1/e909
Article
Is MS affecting the CNS only? Lessons from clinic to myelin pathophysiology.
Autor/s:
Oudejans E, Luchicchi A, Strijbis EMM, Geurts JJG, van Dam AM.
Views and Reviews
Any publicació:
2021
Número de revista:
Neurology Neuroimmunology & Neuroinflammation vol. 8 n. 1
https://nn.neurology.org/content/8/1/e914
Article de revisió
Targeting B Cells to Modify MS, NMOSD, and MOGAD: Part 1.
Autor/s:
Graf J, Mares J, Barnett M, Aktas O, Albrecht P, Zamvil SS, Hartung HP.
Views and Reviews
Any publicació:
2021
Número de revista:
Neurology Neuroimmunology & Neuroinflammation vol. 8 n. 1
https://nn.neurology.org/content/8/1/e918
Article de revisió
Targeting B Cells to Modify MS, NMOSD, and MOGAD: Part 2.
Autor/s:
Graf J, Mares J, Barnett M, Aktas O, Albrecht P, Zamvil SS, Hartung HP.
Views and Reviews
Any publicació:
2021
Número de revista:
Neurology Neuroimmunology & Neuroinflammation vol. 8 n. 1
https://nn.neurology.org/content/8/1/e919
Article de revisió
Chitinases and chitinase-like proteins as biomarkers in neurologic disorders.
Autor/s:
Pinteac R, Montalban X, Comabella M.
Views and Reviews
Any publicació:
2021
Número de revista:
Neurology Neuroimmunology & Neuroinflammation vol. 8 n. 1
https://nn.neurology.org/content/8/1/e921
Article de revisió
Presentations and mechanisms of CNS disorders related to COVID-19.
Autor/s:
Bodro M, Compta Y, Sánchez-Valle R.
Views and Reviews
Any publicació:
2021
Número de revista:
Neurology Neuroimmunology & Neuroinflammation vol. 8 n. 1
https://nn.neurology.org/content/8/1/e923
Article
Treating MS after surviving PML: Discrete strategies for rescue, remission, and recovery patient 1: From the National Multiple Sclerosis Society Case Conference Proceedings.
Autor/s:
Anadani N, Hyland M, Cruz RA, Lisak R, Costello K, Major EO, Jassam Y, Meltzer E, Varkey TC, Parsons MS, Goodman AD, Graves JS, Newsome S, Zamvil SS, Frohman EM, Frohman TC.
Diagnostic and Treatment Challenges
Any publicació:
2021
Número de revista:
Neurology Neuroimmunology & Neuroinflammation vol. 8 n. 1
https://nn.neurology.org/content/8/1/e929
Article
Treating MS after surviving PML: Discrete strategies for rescue, remission, and recovery patient 2: From the National Multiple Sclerosis Society Case Conference Proceedings.
Autor/s:
Cruz RA, Hogan N, Sconzert J, Sconzert M, Major EO, Lisak RP, Melamed E, Varkey TC, Meltzer E, Goodman A, Komogortsev O, Parsons MS, Costello K, Graves JS, Newsome S, Zamvil SS, Frohman EM, Frohman TC.
Diagnostic and Treatment Challenges
Any publicació:
2021
Número de revista:
Neurology Neuroimmunology & Neuroinflammation vol. 8 n. 1
https://nn.neurology.org/content/8/1/e930
Article
Correction
Correction for : Uher T, Schaedelin S, Srpova B, Barro C, Bergsland N, Dwyer M, Tyblova M, Vodehnalova K, Benkert P, Oechtering J, Leppert D, Naegelin Y, Krasensky J, Vaneckova M, Kubala Havrdova E, Kappos L, Zivadinov R, Horakova D, Kuhle J, Kalincik T. Monitoring of radiologic disease activity by...
Any publicació:
2021
Número de revista:
Neurology Neuroimmunology & Neuroinflammation vol. 8 n. 1
https://nn.neurology.org/content/8/1/e934
Article
Correction
Corrector for: Winklmeier S, Schlüter M, Spadaro M, Thaler FS, Vural A, Gerhards R, Macrini C, Mader S, Kurne A, Inan B, Karabudak R, Özbay FG, Esendagli G, Hohlfeld R, Kümpfel T, Meinl E. Identification of circulating MOG-specific B cells in patients with MOG antibodies. Neurol Neuroimmunol...
Any publicació:
2021
Número de revista:
Neurology Neuroimmunology & Neuroinflammation vol. 8 n. 1
https://nn.neurology.org/content/8/1/e938
Article
Correction
Correction for: Novi G, Rossi T, Pedemonte E, Saitta L, Rolla C, Roccatagliata L, Inglese M, Farinini D. Acute disseminated encephalomyelitis after SARS-CoV-2 infection. Neurol Neuroimmunol Neuroinflamm. 2020 Jun 1;7(5):e797. doi: 10.1212/NXI.0000000000000797. PMID: 32482781
Any publicació:
2021
Número de revista:
Neurology Neuroimmunology & Neuroinflammation vol. 8 n. 1
https://nn.neurology.org/content/8/1/e949

Una iniciativa de:

Cercador

Neurology Neuroimmunology & Neuroinflammation vol. 8 n. 1

Neurology Neuroimmunology & Neuroinflammation vol. 8 n. 1

En aquest número

N2 year in review.

Obesity's role in MS: An intervention target with possible interactions.

Chitinase 3-like 1 and neurofilament light chain in CSF and CNS atrophy in MS.

Mild progressive multifocal leukoencephalopathy after switching from natalizumab to ocrelizumab.

Clostridium bolteae is elevated in neuromyelitis optica spectrum disorder in India and shares sequence similarity with AQP4.

Laquinimod dampens IL-1β signaling and Th17-polarizing capacity of monocytes in patients with MS.

Anti-CD20 therapies and pregnancy in neuroimmunologic disorders: A cohort study from Germany.

Placental transfer of NMDAR antibodies causes reversible alterations in mice.

Seizure-related 6 homolog like 2 autoimmunity: Neurologic syndrome and antibody effects.

Eastern equine encephalitis and use of IV immunoglobulin therapy and high-dose steroids.

Time course of dementia following sepsis in German health claims data.

Mendelian randomization study shows no causal effects of serum urate levels on the risk of MS.

Overlapping central and peripheral nervous system syndromes in MOG antibody-associated disorders.

High serum neurofilament associates with diffuse white matter damage in MS.

Mesenchymal stem cell-derived neural progenitors in progressive MS: Two-year follow-up of a phase I study.

Interleukin-15 enhances proinflammatory T-cell responses in patients with MS and EAE.

Overweight/obesity in young adulthood interacts with aspects of EBV infection in MS etiology.

LGI1 encephalitis with squamous lung-cell carcinoma: Resolution after tumor resection.

A case of neonatal onset multisystem inflammatory disease supporting a role of interleukin-1β in moyamoya syndrome.

Tumefactive inflammatory lesions in juvenile metachromatic leukodystrophy.

Combination of teriflunomide and interferon as follow-up therapy after fingolimod-associated PML.

Intermediate uveitis associated with MS: Diagnosis, clinical features, pathogenic mechanisms, and recommendations for management.

Is MS affecting the CNS only? Lessons from clinic to myelin pathophysiology.

Targeting B Cells to Modify MS, NMOSD, and MOGAD: Part 1.

Targeting B Cells to Modify MS, NMOSD, and MOGAD: Part 2.

Chitinases and chitinase-like proteins as biomarkers in neurologic disorders.

Presentations and mechanisms of CNS disorders related to COVID-19.

Treating MS after surviving PML: Discrete strategies for rescue, remission, and recovery patient 1: From the National Multiple Sclerosis Society Case Conference Proceedings.

Treating MS after surviving PML: Discrete strategies for rescue, remission, and recovery patient 2: From the National Multiple Sclerosis Society Case Conference Proceedings.

Correction

Correction

Correction

Trobes a faltar informació? Fes-nos arribar els teus suggeriments!